期刊文献+

口服二巯丁二酸对肝豆状核变性临床疗效及尿铜的影响 被引量:5

Copper excretion in 20 cases with hepatolenticular degeneration treated by DMSA
下载PDF
导出
摘要 20例肝豆状核变性(HLD)患者,男11例,女9例。年龄10~37岁(平均20±6.4岁)。口服二巯丁二酸(DMSA)70mg/kg.d,观察8周,结果表明:7例显效,12例好转,1例无效,有效率达95%。疗前与疗后1~8周24h尿铜比较,结果显示:疗后各周及疗后总平均尿铜值均显著高于疗前。其尿排铜增高与临床疗效相一致。治疗期6例出现齿龈出血、皮下瘀斑外,未见其他副反应。说明DMSA是治疗HLD的一种较理想的驱铜药物。 Abstract Copper excretion in 2 0 cases with hepatolenticular degeneration(HLD)treated by DMSA isreported.It included 11 males and 9 females with age ranging from 10 to 37 years(mean age 20±6.4).DMSA capsules were qiven orally at dosage of 70 mg/kg.d for 8 weeds.Results showedthat seven cases(35%)were gignificantly improved,12(60%)improved and one paticnt(5%)was not effective. Increase in urinary copper excretion coincided with clinical improvement.Gingi-val hemorrhage and ecchymosis occurred in 6 patients during treatment.It suggested that DMSA isan effective agent for HLD.
出处 《临床神经病学杂志》 CAS 1995年第2期83-85,共3页 Journal of Clinical Neurology
  • 相关文献

同被引文献40

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部